About Sernova Corp. (TSE:SVA)
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Biopharmaceuticals
- Sub-Industry: N/A
- Symbol: TSE:SVA
- CUSIP: N/A
- Web: www.sinovac.com/
- Trailing P/E Ratio: N/A
- P/E Growth: N/A
- Net Margins: 14.90%
- Return on Equity: 11.34%
- Return on Assets: 8.92%
Frequently Asked Questions for Sernova Corp. (TSE:SVA)
What is Sernova Corp.'s stock symbol?
Sernova Corp. trades on the Toronto Stock Exchange (TSX) under the ticker symbol "SVA."
Who are some of Sernova Corp.'s key competitors?
Some companies that are related to Sernova Corp. include Biogen (BIIB), Alexion Pharmaceuticals (ALXN), BioMarin Pharmaceutical (BMRN), Abcam Plc (ABC), Anika Therapeutics (ANIK), Myovant Sciences Ltd (MYOV), Syros Pharmaceuticals (SYRS), ChemoCentryx (CCXI), Syndax Pharmaceuticals (SNDX), Strongbridge Biopharma PLC (SBBP), Synlogic (SYBX), Mereo BioPharma Group PLC (MPH), Fortress Biotech (FBIO), Kamada (KMDA), Peregrine Pharmaceuticals (PPHM), Kadmon Holdings (KDMN), Vericel Corp (VCEL) and MediWound (MDWD).
Who are Sernova Corp.'s key executives?
Sernova Corp.'s management team includes the folowing people:
- Weidong Yin, Chairman of the Board, President, Chief Executive Officer, Secretary
- Nan Wang, Chief Financial Officer
- Ming Xia, Vice President - Sales and Marketing of Sinovac Beijing
- Simon J. Anderson, Independent Director
- Jue Lee, Independent Director
- Yuk Lam Lo, Independent Director
- Meng Mei, Independent Director
How do I buy Sernova Corp. stock?
MarketBeat Community Rating for Sernova Corp. (TSE SVA)MarketBeat's community ratings are surveys of what our community members think about Sernova Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Shares of Sernova Corp. and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
Consensus Ratings for Sernova Corp. (TSE:SVA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Sernova Corp. (TSE:SVA)
Analysts' Ratings History for Sernova Corp. (TSE:SVA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Sernova Corp. (TSE:SVA)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Sernova Corp. (TSE:SVA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Sernova Corp. (TSE:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Sernova Corp. (TSE:SVA)Insider Trades by Quarter for Sernova Corp. (TSE:SVA)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/17/2017||James Todd Parsons||Director||Sell||272||C$0.25||C$68.00|
|4/13/2017||James Todd Parsons||Director||Sell||166,500||C$0.25||C$41,625.00|
|4/11/2017||James Todd Parsons||Director||Sell||33,500||C$0.25||C$8,375.00|
Headline Trends for Sernova Corp. (TSE:SVA)
Latest Headlines for Sernova Corp. (TSE:SVA)
Loading headlines, please wait.
Sernova Corp. (SVA) Chart for Monday, October, 23, 2017